The authors declare no conflicts of interest.
Article
Enhanced red-emitting railroad worm luciferase for bioassays and bioimaging†
Article first published online: 28 OCT 2009
DOI: 10.1002/pro.279
Copyright © 2009 The Protein Society
Additional Information
How to Cite
Li, X., Nakajima, Y., Niwa, K., Viviani, V. R. and Ohmiya, Y. (2010), Enhanced red-emitting railroad worm luciferase for bioassays and bioimaging. Protein Science, 19: 26–33. doi: 10.1002/pro.279
- †
Publication History
- Issue published online: 6 JAN 2010
- Article first published online: 28 OCT 2009
- Accepted manuscript online: 28 OCT 2009 12:00AM EST
- Manuscript Accepted: 9 OCT 2009
- Manuscript Received: 10 JUL 2009
Funded by
- NEDO grant (Chemical Substance Management Technology Projects of Development of Simple and Highly Functional Hazard Assessment Methods)
- The Ministry of Economy, Trade and Industry of Japan
- Abstract
- Article
- References
- Cited By
Keywords:
- red-emitting luciferase;
- enhanced activity;
- thermostable mutant;
- bioassays;
- bioimaging
Abstract
A luciferase from the railroad worm (Phrixothrix hirtus) is the only red-emitting bioluminescent enzyme in nature that is advantageous in multicolor luciferase assays and in bioluminescence imaging (BLI). However, it is not used widely in scientific or industrial applications because of its low activity and stability. By using site-directed mutagenesis, we produced red-emitting mutants with higher activity and better stability. Compared with the wild-type (WT), the luminescent activities from extracts of cultured mammalian cells expressing mutant luciferase were 9.8-fold in I212L/N351K, 8.4-fold in I212L, and 7.8-fold in I212L/S463R; and the cell-based activities were 3.6-fold in I212L/N351K and 3.4-fold in N351K. The remaining activities after incubation at 37°C for 10 min were 50.0% for I212L/S463R, 31.8% for I212L, and 23.0% for I212L/N351K, but only 5.2% for WT. To demonstrate an application of I212L/N351K, cell-based BLI was performed, and the luminescence signal was 3.6-fold higher than in WT. These results indicate that the mutants might improve the practicability of this signaling in bioassays and BLI.

1469-896X/asset/olbannerleft.gif?v=1&s=d218899ae53b2862ab119790ed504b8d72122fb3)
1469-896X/asset/olbannerright.gif?v=1&s=59470eb9a1d9b7b13b1be75e9445e6c46ee2214f)
